Leading pharmaceutical company in the Baltic States “Grindeks” has launched a manufacturing unit of ointments and gels.
It is one of the most modern in the Baltic States and it meets world-class standards of pharmaceutical manufacturing. The amount of investments is about 2.5 million lats, including 448.67 thousand lats of co-financing of the EU structural funds. According to analysts’ prognoses the investments are going to be recovered within 2 years.
Comments
Now there is no comments, be the first who comments the article